Home › Funds › Ikarian Capital, LLC › CPIX
Ikarian Capital, LLC position in CPIX
CUMBERLAND PHARMACEUTICALS I · Health Care
Ikarian Capital, LLC reported holding 503,153 shares of CPIX (CUMBERLAND PHARMACEUTICALS I) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 0.58% of its reported portfolio and ranking #46 among its reported holdings. Ikarian Capital, LLC has disclosed CPIX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's CPIX position evolved
Ikarian Capital, LLC first disclosed a stake in CPIX in Q1 2025 at 740,000 shares (US$3.1M). The position peaked in Q3 2026 at 503,153 shares, worth US$3.9M. Across 7 filings, Ikarian Capital, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 503,153 shares valued at US$3.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 740.00K | $3.13M | New |
| Q2 2025 | 595.93K | $2.00M | Reduce |
| Q3 2025 | 555.93K | $1.73M | Reduce |
| Q4 2025 | 555.93K | $2.21M | Hold |
| Q1 2026 | 553.15K | $1.80M | Hold |
| Q2 2026 | 503.15K | $3.26M | Reduce |
| Q3 2026 | 503.15K | $3.94M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CPIX and 13F data
CPIX (CUMBERLAND PHARMACEUTICALS I) is a Health Care company. 28 other funds we track also report a position in CPIX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held CPIX?
Ikarian Capital, LLC has disclosed CPIX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Ikarian Capital, LLC's current position in CPIX?
As of Q3 2026, Ikarian Capital, LLC holds 503.15K shares of CPIX (CUMBERLAND PHARMACEUTICALS I), valued at $3.94M, representing 0.58% of its reported portfolio and ranking #46.
Has Ikarian Capital, LLC been buying or selling CPIX?
In the latest 13F filing (Q3 2026), Ikarian Capital, LLC held unchanged its position in CPIX. The position peaked in Q3 2026 at 503.15K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.